INTRODUCTION {#sec1-1}
============

Oxidative stress plays a great role in the pathophysiological mechanisms involved in cardiovascular diseases. Increased production of free radicals and oxidative cellular damages has been implicated in various cardiovascular diseases such as atherosclerosis, high blood pressure, heart failure, diabetes and hypercholesterolemia ([@ref1]). Oxidative stress is mainly caused by the production of large amounts of reactive oxygen species (ROS) and reduction of antioxidant capacity. Superoxide anion, hydroxyl radicals, lipid radicals and hydrogen peroxide (H~2~O~2~) are the examples of ROS. In the vasculature, ROS cause inactivation of nitric oxide, oxidation of low density lipoprotein (LDL), inflammation and impairment of endothelial function associated with hypertension and atherosclerosis ([@ref2][@ref3][@ref4]).

Antioxidants are substances that protect endothelial cells against oxidative toxicity by preventing ROS formation, neutralizing the free radicals and inhibiting oxidation reactions ([@ref5][@ref6][@ref7]). A growing body of evidence has shown a relation between supplementation with antioxidants and reduction in morbidity and mortality from cardiovascular diseases. Antioxidants may improve endothelial function through prevention from lipid peroxidation in LDL, enhancement of endothelium-dependent vasodilatory responses and modulation of endothelium-leukocyte interactions ([@ref8][@ref9][@ref10]).

*Melissa officinalis* L. (lemon balm) is a traditional herbal medicine with a large variety of effects such as spasmolytic, analgesic, hypnotic, hepatoprotective, antibacterial, anticancer, antioxidant and antiviral activities ([@ref11][@ref12][@ref13][@ref14][@ref15]). Lemon balm grows in central and southern Europe, North America, and in Asia Minor. In Iranian traditional medicine, it is used to treat a wide range of diseases including fever, headaches, influenza, bloating, indigestion, colic, nausea, anemia, dizziness, fainting, weakness, asthma, bronchitis, amenorrhea, heart failure, arrhythmia, insomnia, epilepsy, depression, neurological disorders, wounds and injuries ([@ref16][@ref17]). Lemon balm contains many antioxidant compounds including flavonoids such as naringin and hesperidin and also hydroxycinnamic acid derivatives such as rosmarinic acid, m-coumaric acid and caffeic acid ([@ref18][@ref19]).

In this study, protective effect of hydroalcoholic extract obtained from the aerial parts of *M. officinalis* was investigated in human umbilical vein endothelial cells (HUVECs) under oxidative stress induced by H~2~O~2~. To assure the safety of *M. officinalis* extract on HUVECs, the toxicity of this herbal extract was also evaluated.

MATERIALS AND METHODS {#sec1-2}
=====================

 {#sec2-1}

### Chemicals {#sec3-1}

Dulbecco's Modified Eagle's Medium (DMEM) was obtained from GIBCO Life Technologies (Paisley, Scotland). Fetal bovine serum (FBS) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay kit was purchased from Bioidea Co. (Tehran, Iran). The assay kits for measurement of hydroperoxides and ferric reducing antioxidant power (FRAP) were purchased from Hakiman Shargh Research Co. (Isfahan, Iran). All other chemicals were from Merck Co., Germany.

### Plant material and preparation of extract {#sec3-2}

The aerial parts of *M. officinalis* were collected from Hasan Abad Jarghooyeh in the Isfahan Province during May 2014. After authentication, a voucher specimen (No. 3395) was deposited at the Herbarium of the School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences. For preparation of hydroalcoholic extract, the air-dried aerial parts of *M. officinalis* were powdered and extracted three times with ethanol:water (70:30) using maceration process at room temperature for 72 h. After filtration and evaporation of solvent under reduced pressure using a rotary evaporator, the obtained extract was freeze-dried and the residue was stored at -20 °C. The yield of the plant extract was 16.8 % (w/w). The extract was dissolved in dimethyl sulfoxide (DMSO) 0.8% and diluted with cell culture medium to get different concentrations as per requirement.

### Determination of total phenolic content {#sec3-3}

The total phenolic content of *M. officinalis* extract was estimated using Folin-Ciocalteu assay. Briefly, the plant samples were mixed with sodium bicarbonate (20%) and diluted Folin's reagent. After 2 h, the absorbance was measured at 765 nm. Each experiment was assayed in triplicate. The total phenolic content was estimated using a standard curve obtained from different concentrations of gallic acid as the standard reference ([@ref20]).

### Cell culture {#sec3-4}

Human umbilical vein endothelial cells were obtained from the National Cell Bank of Iran (Pasteur Institute of Iran, Iran, Tehran,). The cells were cultured in DMEM containing 10% FBS, 100 U/mL penicillin and 100 μg/mL streptomycin. Cultures were maintained under normal culture condition (5% CO~2~ and 95% humidified air at 37 °C).

### Cell viability evaluation {#sec3-5}

MTT assay was used to determine the effect of *M. officinalis* extract on viability of HUVECs. This assay was based on the reduction of tetrazolium salt by mitochondrial dehydrogenases of viable cells and performed for evaluation of both probable cytotoxic and cytoprotective effects of *M. officinalis* extract in this research ([@ref21]).

At first, the probable cytotoxicity of the extract (25 to 1000 μg/mL) on normal HUVECs was assessed using MTT method. Briefly, at the end of 24 h incubation period, HUVECs were treated with different concentrations of freshly prepared *M. officinalis* extract and incubated for an additional 24 h at 37 °C. After washing out with phosphate buffered saline (PBS), new medium containing MTT reagent was added to each well and incubated for 3 h at 37 °C. MTT reaction with living cells creates insoluble foramazan crystals with purple color. After dissolution of foramazan crystals by adding DMSO, the absorbance was measured at 570 nm by a microplate reader (BioTek Instruments, PowerWave XS, Wincoski, USA).

The cytoprotective effect of *M. officinalis* extract on HUVECs was also evaluated under oxidative stress induced by hydrogen peroxide. The cells were pre-incubated with the extract (25 to 500 μg/mL) or vitamin C (100 μg/mL as the standard reference) for 24 h at 37 °C. After removal of the medium and washing out with PBS, HUVECs were exposed to H~2~O~2~ 0.5 mM for 2 h. The rest of the experiment was completed as above. The cells without any exposure to the extract or H~2~O~2~ were considered as negative control. The cells with exposure to vitamin C were used as the positive control. The viability of treated samples was assessed by comparison of the absorbance of different concentrations of the samples with negative control according to the following formula and each experiment was tested in triplicate ([@ref21]):
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### Measurement of extra- and intra-cellular hydroperoxides concentration {#sec3-6}

The effects of *M. officinalis* extract on intra- and extra-cellular level of hydroperoxides were evaluated based on the ferrous ion oxidation by xylenol orange reagent (FOX-1) ([@ref22]). The FOX-1 reagent containing ammonium ferric sulfate in aqueous medium with sorbitol was prepared according to the instructions of the kit manufacturer.

The HUVECs were pretreated with different concentrations of the extract and exposed to the H~2~O~2~. Then 10 μL of supernatant of the cells or the cell lysates from each well was mixed with 190 μL of FOX-1 reagent. After incubation for 30 min at 40 °C, absorbances of the samples were determined using a microplate reader/spectrophotometer at 540 nm. The hydroperoxides content of the samples were estimated as H~2~O~2~ equivalents from a H~2~O~2~ standard curve.

### Measurement of cell-free and intra- and extra-cellular ferric reducing antioxidant power {#sec3-7}

The effects of *M. officinalis* extract on intra- and extra-cellular FRAP was determined by Benzie and Strain method ([@ref23]). This method measures the total antioxidant capacity based on the reduction of ferric-tripyridyltriazine (TPTZ) complex to ferrous form by spectrophotometric assay.

After pretreatment of HUVECs with different concentrations of *M. officinalis* extract, the cells were exposed to oxidative stress by H~2~O~2~.

The FRAP reagent containing TPTZ/ferric chloride/acetate buffer was freshly prepared according to the instructions of the kit manufacturer. For each well, 10 μL of the supernatant of the cells or the cell lysates was added to 200 μL of FRAP reagent.

The FRAP level was also evaluated on samples without cells. These samples contained different concentrations of *M. officinalis* extract. The reaction mixture was incubated for 40 min at 40 °C and absorbance was measured at 570 nm using a microplate reader/spectrophotometer.

The FRAP value of samples was calculated using a standard curve of FeSO~4~.7H~2~O.

### Statistical analysis {#sec3-8}

Data were presented as mean ± standard error of mean (SEM) in triplicate experiments. Statistical analysis was done by one-way analysis of variance (ANOVA) followed by Tukey post-hoc test (SPSS software version 16.0). *P* value \< 0.05 was considered as the criteria for significant differences.

RESULTS {#sec1-3}
=======

 {#sec2-2}

### Total phenolic content {#sec3-9}

The total phenolic content of the hydroalcoholic extract of *M. officinalis* was estimated as 28.84 ± 4.04 mg gallic acid equivalent/g of the dried aerial parts of the plant.

### Effect of M. officinalis extract on human umbilical vein endothelial cells viability {#sec3-10}

In order to evaluate the probable cytotoxicity of *M. officinalis* extract on HUVECs, the cell viability was measured by MTT assay. There was no inhibitory effect on HUVECs viability after exposure to *M. officinalis* extract at the concentrations of 25 - 500 μg/mL for 24 h. However, the concentration of 1000 μg/mL of the extract significantly decreased the HUVECs viability ([Fig. 1](#F1){ref-type="fig"}).

![Effect of *M. officinalis* extract on human umbilical vein endothelial cell viability determined by MTT assay. Cells were incubated with different concentrations of the extract (25-1000 μg/mL) for 24 h. Values are the means ± SEM of three independent experiments. \*\*\**P* \< 0.001 versus control (untreated cells).](RPS-11-383-g002){#F1}

### Cytoprotective effect of M. officinalis extract against H~2~O~2~-induced oxidative stress {#sec3-11}

[Fig. 2](#F2){ref-type="fig"} shows the cytoprotective effect of *M. officinalis* extract against the oxidative damage induced by H~2~O~2~ using the MTT method.

![Effect of *M. officinalis* extract on human umbilical vein endothelial cells viability in H~2~O~2~-induced oxidative stress. Cells were incubated with H~2~O~2~ (0.5 mM, for 2 h) after pretreatment with the extract (25-500 μg/mL) or vitamin C (100 μg/mL). The cell viability was determined by the MTT assay. Values are the means ± SEM of three independent experiments. ^\#\#\#^*P* \< 0.001 versus control (untreated cells), \**P* \< 0.05 and \*\*\**P* \< 0.001 versus H~2~O~2~ stimulated cells.](RPS-11-383-g003){#F2}

The exposure of HUVECs to 0.5 mM H~2~O~2~ for 2 h remarkably reduced cell viability (*P* \< 0.001).

Pretreatment of HUVECs with *M. officinalis* extract at the concentrations of 100-500 μg/mL significantly decreased the cell death resulted from the exposure to H~2~O~2~. The protective effect was not observed at concentrations of 25 and 50 μg/mL of the extract.

### Effects of M. officinalis extract on intra- and extra-cellular concentration of hydroperoxides {#sec3-12}

The effects of *M. officinalis* extract on intra- and extra-cellular hydroperoxides concentration estimated as H~2~O~2~ equivalents by FOX1 method are shown in [Fig. 3](#F3){ref-type="fig"}. The levels of hydroperoxides were markedly reduced in intra- and extra-cellular fluids after pretreatment of the HUVECs with *M. officinalis* extract at the concentrations of 100-500 μg/mL compared with the control group.

![Effect of *M. officinalis* extract on intra- and extra-cellular concentration of hydroperoxides in human umbilical vein endothelial cells measured as H~2~O~2~ equivalents determined by ferrous ion oxidation by xylenol orange reagent method. Cells were incubated with H~2~O~2~ (0.5 mM, for 2 h) after pretreatment with the extract (25-500 μg/mL) or vitamin C (100 μg/mL). Values are the means ± SEM of three independent. ^\#\#\#^*P* \< 0.001 versus control (untreated cells), \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001 versus H~2~O~2~ stimulated cells.](RPS-11-383-g004){#F3}

### Effects of M. officinalis extract on cell-free and intra- and extra-cellular ferric reducing antioxidant power value {#sec3-13}

In cell-free assay, the FRAP value of the *M. officinalis* extract which was expressed as equivalence of ferrous sulphate showed increasing trend in total antioxidant capacity with the extract concentrations ([Fig. 4](#F4){ref-type="fig"}). In cell-based assay, the FRAP value was markedly increased after pre-treatment with the extract at the concentration range of 100-500 μg/mL in intra-cellular fluids compared with the control group. Pre-incubation with the extract at the concentrations of 50 - 500 μg/mL also increased the total antioxidant capacity in extra-cellular fluids in a concentration-dependent manner ([Fig. 5](#F5){ref-type="fig"}).

![Ferric reducing antioxidant power values of different concentrations of *M. officinalis* extract and vitamin C (25-1000 μg/mL) determined as ferrous sulphate equivalents. Values are the means ± SEM of three independent experiments. \*\**P*\<0.01 and \*\*\**P*\<0.001 versus vitamin C control group at the same concentration.](RPS-11-383-g005){#F4}

![Effect of *M. officinalis* extract on intra- and extra-cellular ferric reducing antioxidant power value in human umbilical vein endothelial cells determined as ferrous sulphate equivalents. Cells were incubated with H~2~O~2~ (0.5 mM, for 2 h) after pretreatment with the extract (25-1000 μg/mL) or vitamin C (100 μg/mL). Values are the means ± SEM of three independent experiments. \**P*\<0.05, \*\**P*\<0.01 and \*\*\**P*\<0.001 versus H~2~O~2~ stimulated cells.](RPS-11-383-g006){#F5}

DISCUSSION {#sec1-4}
==========

This investigation explored the antioxidant effect of *M. officinalis* hydroalcoholic extract as well as its cytoprotective effect against H~2~O~2~ -induced toxicity in HUVECs. The plant extract protected the cells against oxidative stress at the concentrations of 100-500 μg/mL. The extract decreased concentration of hydroperoxides in intra- and extra-cellular fluids at the concentration range of 100-500 μg/mL and increased FRAP value in intra-cellular fluid at the concentrations of 100-500 μg/mL and in extra-cellular fluid at the concentrations of 50-500 μg/mL.

The role of endothelial cells in the regulation of physiological functions of vascular system has been elucidated in many investigations and studies as well as the role of oxidative stress in the impairment of endothelium function ([@ref1]). In the present study, HUVEC as a normal cell type with good homogeneity, rapid expansion property and well-characterized surface markers was used in a model of oxidative stress on endothelial cells ([@ref24]).

We also used FRAP assay for evaluation of antioxidant effects of *M. officinalis* extract in the present investigation. This assay is a simple, inexpensive and reproducible method for measuring antioxidant power in both in vitro and biological fluids ([@ref23]).

*M. officinalis* has earlier been revealed to have antioxidant activities ([@ref11][@ref18][@ref19]). However, the present study was planned to confirm this property at the cellular level. The detected cytoprotective effect against oxidative injury of HUVECs is possibly due to its various antioxidant phytochemicals. Rosmarinic acid has been identified as the major component of *M. officinalis* extract ([@ref18]). This polyphenolic compound is a caffeic acid derivative with favorable cardiovascular effects such as antioxidant, anti-inflammatory, anti-apoptotic, cyto- and cardio-protective activities ([@ref25]). Rosmarinic acid is a superoxide scavenger which can inhibit LDL oxidation in human aortic endothelial cells ([@ref26]). The structure-activity relationship studies have shown the role of an ortho dihydroxyphenyl group and the conjugated double bond in the C3 carbon chain in its scavenging activity ([@ref27]). The antioxidant effect of rosmarinic acid also contributes in its anti-angiogenesis activity through reducing the expression of H~2~O~2~ -dependent vascular endothelial growth factor, decreasing release of IL-8 from endothelial cells and inhibiting the proliferation, migration, adhesion, and tube formation of HUVECs ([@ref27]).

Caffeic acid, another antioxidant phenolic compound in the extract of *M. officinalis*, has potential to reduce the risk of cardiovascular disorders by inhibiting the production of ROS ([@ref28]). It can improve resistance of the cells against oxidative stress by inhibition of lipid peroxidation and reduction of glutathione depletion ([@ref29]). Hesperidin is another phenolic constituent of *M. officinalis* with cytoprotective effect which has increased the cell viability by providing powerful antioxidant protection against paraquat and H~2~O~2~ -induced oxidative stress ([@ref30]). The major component s of the essential oil of the lemon balm leaf, citronellal and citral are also antioxidant compounds with superoxide scavenging activity ([@ref31]).

CONCLUSION {#sec1-5}
==========

In conclusion, the results of this study revealed that hydroalcoholic extract of *M. officinalis* aerial parts has the potential to protect HUVECs under oxidative stress induced by H~2~O~2~. Due to the presence of various antioxidant phytochemicals, the plant extract may have potential benefits in human health through preventing harmful oxidative injuries.
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